Logo image of AAL

AMERICAN AIRLINES GROUP INC (AAL) Stock Fundamental Analysis

NASDAQ:AAL - Nasdaq - US02376R1023 - Common Stock - Currency: USD

11.0575  -0.78 (-6.61%)

After market: 11.06 +0 (+0.02%)

Fundamental Rating

4

AAL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 23 industry peers in the Passenger Airlines industry. While AAL is still in line with the averages on profitability rating, there are concerns on its financial health. AAL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AAL had positive earnings in the past year.
AAL had a positive operating cash flow in the past year.
In multiple years AAL reported negative net income over the last 5 years.
AAL had a positive operating cash flow in 4 of the past 5 years.
AAL Yearly Net Income VS EBIT VS OCF VS FCFAAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.09%, AAL is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
AAL has a Return On Invested Capital of 5.98%. This is in the better half of the industry: AAL outperforms 60.87% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AAL is below the industry average of 10.40%.
The last Return On Invested Capital (5.98%) for AAL is above the 3 year average (5.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.09%
ROE N/A
ROIC 5.98%
ROA(3y)0.96%
ROA(5y)-2.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.54%
ROIC(5y)N/A
AAL Yearly ROA, ROE, ROICAAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

AAL has a Profit Margin (1.26%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of AAL has declined.
AAL has a Operating Margin (5.50%) which is in line with its industry peers.
In the last couple of years the Operating Margin of AAL has declined.
AAL has a better Gross Margin (64.23%) than 78.26% of its industry peers.
In the last couple of years the Gross Margin of AAL has remained more or less at the same level.
Industry RankSector Rank
OM 5.5%
PM (TTM) 1.26%
GM 64.23%
OM growth 3YN/A
OM growth 5Y-5.79%
PM growth 3YN/A
PM growth 5Y-15.78%
GM growth 3Y3.63%
GM growth 5Y0.67%
AAL Yearly Profit, Operating, Gross MarginsAAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AAL is destroying value.
The number of shares outstanding for AAL has been increased compared to 1 year ago.
The number of shares outstanding for AAL has been increased compared to 5 years ago.
AAL has a better debt/assets ratio than last year.
AAL Yearly Shares OutstandingAAL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AAL Yearly Total Debt VS Total AssetsAAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 0.69, we must say that AAL is in the distress zone and has some risk of bankruptcy.
AAL has a Altman-Z score of 0.69. This is comparable to the rest of the industry: AAL outperforms 52.17% of its industry peers.
The Debt to FCF ratio of AAL is 18.68, which is on the high side as it means it would take AAL, 18.68 years of fcf income to pay off all of its debts.
AAL's Debt to FCF ratio of 18.68 is fine compared to the rest of the industry. AAL outperforms 60.87% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.68
Altman-Z 0.69
ROIC/WACC0.88
WACC6.77%
AAL Yearly LT Debt VS Equity VS FCFAAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 0.52 indicates that AAL may have some problems paying its short term obligations.
AAL has a worse Current ratio (0.52) than 65.22% of its industry peers.
AAL has a Quick Ratio of 0.52. This is a bad value and indicates that AAL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.42, AAL is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.42
AAL Yearly Current Assets VS Current LiabilitesAAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

4

3. Growth

3.1 Past

AAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.22%.
Measured over the past years, AAL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.21% on average per year.
AAL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.92%.
Measured over the past years, AAL shows a small growth in Revenue. The Revenue has been growing by 3.44% on average per year.
EPS 1Y (TTM)-26.22%
EPS 3YN/A
EPS 5Y-17.21%
EPS Q2Q%-73.53%
Revenue 1Y (TTM)1.92%
Revenue growth 3Y21.96%
Revenue growth 5Y3.44%
Sales Q2Q%-0.15%

3.2 Future

AAL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.02% yearly.
The Revenue is expected to grow by 3.27% on average over the next years.
EPS Next Y-51.88%
EPS Next 2Y3.86%
EPS Next 3Y11.51%
EPS Next 5Y17.02%
Revenue Next Year1.29%
Revenue Next 2Y3.62%
Revenue Next 3Y4.06%
Revenue Next 5Y3.27%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AAL Yearly Revenue VS EstimatesAAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
AAL Yearly EPS VS EstimatesAAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 -10 -15 -20

7

4. Valuation

4.1 Price/Earnings Ratio

AAL is valuated cheaply with a Price/Earnings ratio of 6.66.
AAL's Price/Earnings ratio is rather cheap when compared to the industry. AAL is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.59. AAL is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 5.37, the valuation of AAL can be described as very cheap.
Based on the Price/Forward Earnings ratio, AAL is valued cheaper than 86.96% of the companies in the same industry.
AAL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.39.
Industry RankSector Rank
PE 6.66
Fwd PE 5.37
AAL Price Earnings VS Forward Price EarningsAAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

82.61% of the companies in the same industry are more expensive than AAL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AAL indicates a rather cheap valuation: AAL is cheaper than 86.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.63
EV/EBITDA 4.22
AAL Per share dataAAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.86%
EPS Next 3Y11.51%

0

5. Dividend

5.1 Amount

AAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN AIRLINES GROUP INC

NASDAQ:AAL (6/11/2025, 3:59:50 PM)

After market: 11.06 +0 (+0.02%)

11.0575

-0.78 (-6.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-23 2025-07-23/bmo
Inst Owners68.64%
Inst Owner Change-0.34%
Ins Owners1.18%
Ins Owner Change8.38%
Market Cap7.29B
Analysts73.33
Price Target13.55 (22.54%)
Short Float %10.38%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.44%
Min EPS beat(2)9.67%
Max EPS beat(2)33.2%
EPS beat(4)4
Avg EPS beat(4)33.85%
Min EPS beat(4)2.97%
Max EPS beat(4)89.57%
EPS beat(8)7
Avg EPS beat(8)45.93%
EPS beat(12)9
Avg EPS beat(12)31.66%
EPS beat(16)13
Avg EPS beat(16)25.59%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)0.97%
Revenue beat(4)2
Avg Revenue beat(4)-0.36%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)0.97%
Revenue beat(8)3
Avg Revenue beat(8)-0.41%
Revenue beat(12)3
Avg Revenue beat(12)-0.58%
Revenue beat(16)4
Avg Revenue beat(16)-0.46%
PT rev (1m)-9.41%
PT rev (3m)-36.64%
EPS NQ rev (1m)1.39%
EPS NQ rev (3m)-44.7%
EPS NY rev (1m)-38.7%
EPS NY rev (3m)-62.11%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-7.02%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-4.87%
Valuation
Industry RankSector Rank
PE 6.66
Fwd PE 5.37
P/S 0.13
P/FCF 4.63
P/OCF 1.71
P/B N/A
P/tB N/A
EV/EBITDA 4.22
EPS(TTM)1.66
EY15.01%
EPS(NY)2.06
Fwd EY18.63%
FCF(TTM)2.39
FCFY21.61%
OCF(TTM)6.46
OCFY58.4%
SpS82.17
BVpS-6.84
TBVpS-16.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.09%
ROE N/A
ROCE 8.16%
ROIC 5.98%
ROICexc 7.67%
ROICexgc 9.77%
OM 5.5%
PM (TTM) 1.26%
GM 64.23%
FCFM 2.91%
ROA(3y)0.96%
ROA(5y)-2.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.54%
ROIC(5y)N/A
ROICexc(3y)6.89%
ROICexc(5y)N/A
ROICexgc(3y)8.52%
ROICexgc(5y)N/A
ROCE(3y)7.55%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y3.25%
ROICexc growth 3YN/A
ROICexc growth 5Y2.18%
OM growth 3YN/A
OM growth 5Y-5.79%
PM growth 3YN/A
PM growth 5Y-15.78%
GM growth 3Y3.63%
GM growth 5Y0.67%
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.68
Debt/EBITDA 4.73
Cap/Depr 119.51%
Cap/Sales 4.95%
Interest Coverage 1.57
Cash Conversion 81.53%
Profit Quality 230.07%
Current Ratio 0.52
Quick Ratio 0.42
Altman-Z 0.69
F-Score7
WACC6.77%
ROIC/WACC0.88
Cap/Depr(3y)120.38%
Cap/Depr(5y)92.28%
Cap/Sales(3y)5.27%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.22%
EPS 3YN/A
EPS 5Y-17.21%
EPS Q2Q%-73.53%
EPS Next Y-51.88%
EPS Next 2Y3.86%
EPS Next 3Y11.51%
EPS Next 5Y17.02%
Revenue 1Y (TTM)1.92%
Revenue growth 3Y21.96%
Revenue growth 5Y3.44%
Sales Q2Q%-0.15%
Revenue Next Year1.29%
Revenue Next 2Y3.62%
Revenue Next 3Y4.06%
Revenue Next 5Y3.27%
EBIT growth 1Y-18.14%
EBIT growth 3YN/A
EBIT growth 5Y-2.55%
EBIT Next Year43.06%
EBIT Next 3Y26.24%
EBIT Next 5Y28.58%
FCF growth 1Y-11.41%
FCF growth 3Y64.51%
FCF growth 5YN/A
OCF growth 1Y-1.43%
OCF growth 3Y78.19%
OCF growth 5Y0.87%